A comparative study of machine learning algorithms applied to early detection of cognitive decline using the OASIS-3 dataset, a longitudinal multimodal neuroimaging and clinical cohort of 1378 participants aged 42-95 years, demonstrating the added value of logic-augmented classifiers for early risk stratification.
Abstract
Cognitive decline associated with Alzheimer's disease (AD) and mild cognitive impairment (MCI) represents one of the most critical public health challenges of the twenty-first century, affecting tens of millions of people worldwide. This paper presents a comparative study of machine learning algorithms applied to early detection of cognitive decline using the open access series of imaging studies (OASIS-3) dataset, a longitudinal multimodal neuroimaging and clinical cohort of 1378 participants aged 42-95 years. To avoid data leakage, all features directly encoding a clinical diagnosis, including clinical dementia rating (CDR) scores, diagnostic (DX) codes, and mini-mental state examination (MMSE) results, are excluded; instead, fifteen structural neuroimaging features describing brain morphology (e.g., hippocampal and entorhinal measurements) and neuropsychological sub-test features are selected via a two-stage recursive feature elimination and greedy forward-search procedure. We evaluate six supervised models: logistic regression, support vector machine (SVM), random forest, gradient boosting, K-nearest neighbours (KNN), and CatBoost. Gradient boosting achieves the highest weighted F1-score (0.856) on the held-out test set, followed by CatBoost (0.8482); CatBoost offers approximately $2\times$ lower inference latency. A neurosymbolic post-processing stage using the Scallop probabilistic logic engine identifies 166 participants with measurable structural brain atrophy (reduction in hippocampal volume) prior to a formal clinical diagnosis, demonstrating the added value of logic-augmented classifiers for early risk stratification. Feature-importance analysis identifies white-matter hyperintensity volume (MRI-visible lesions associated with vascular and neurodegenerative damage) and entorhinal/hippocampal measurements as the dominant predictors, consistent with established neurobiological evidence.
Mild cognitive impairment (MCI) is a transitional state between normal aging and dementia, characterized by subtle cognitive decline. While not all individuals with MCI will progress to Alzheimer’s disease (AD), early identification of those at high risk is crucial for timely interventions. Machine learning algorit...
A. Mouiha, Mohamed Taiebine, Jaouad El-Hilaly· Journal of Education and Hea...· 0 citations
The findings support the potential role of structural MRI biomarkers combined with interpretable ML approaches for the classification of cognitive impairment and the integration of demographic variables improved model performance, particularly in binary discrimination tasks, whereas multiclass classification remained m...
Recent progress in AI-driven approaches for AD detection is discussed and the importance of interdisciplinary strategies to facilitate earlier diagnosis, improve patient outcomes, and support more effective management of Alzheimer's disease is underscored.
Hakar Hasan Rasheed, Naaman Omar Yaseen· Academic Journal of Internat...· 0 citations
Overall, artificial intelligence has substantially advanced prediction research in cognitive decline and dementia, but its routine clinical adoption will depend on more rigorous validation, improved transparency, and stronger integration between neuroscience, clinical practice, and data science.
Rubén Sanz-Blasco, M. Fernández-Blázquez, Emilio Verche et al.· Journal of Alzheimer's Disea...· 0 citations
This survey provides a comprehensive synthesis of EEG-based dementia studies published between 2020 and 2025, with a primary focus on Alzheimer’s disease, frontotemporal dementia (FTD), mild cognitive impairment (MCI), and related dementia disorders.
Oluwatoyin Kode, Mitch Hong, Long Nguyen et al.· ET Journal· 0 citations
Alzheimer’s disease (AD) is a progressive neurological disorder and the leading cause of dementia, affecting millions globally. As populations continue to age, AD prevalence is expected to rise significantly, placing substantial burdens on healthcare systems. Early detection of cognitive decline is essential, as interv...
Samaneh Rezaeimanesh, Mohammad Fili, Gui-Ping Hu et al.· IISE Annual Conference &...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.